Seeing Is Believing
CARA is currently covered by 7 analysts with an average price target of $10.6. This is a potential upside of $10.14 (2204.35%) from yesterday's end of day stock price of $0.46.
Cara Therapeutic's activity chart (see below) currently has 48 price targets and 55 ratings on display. The stock rating distribution of CARA is 83.33% BUY, 12.5% SELL and 4.17% HOLD.
Analysts average stock forecasts to be materialized ratio is 41.62% with an average time for these price targets to be met of 283.42 days.
Highest price target for CARA is $12, Lowest price target is $1, average price target is $10.6.
Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 22-Jan-2024. First documented stock forecast 27-Feb-2014.
Currently out of the existing stock ratings of CARA, 20 are a BUY (83.33%), 3 are a SELL (12.5%), 1 are a HOLD (4.17%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
11 months 3 days ago
(22-Jan-2024)
0/4 (0%)
$17.55 (394.38%)
Buy
$2.5
$1.45 (138.10%)
1 years 6 days ago
(19-Dec-2023)
3/15 (20%)
$1.88 (303.23%)
493
Hold
$1
$-0.05 (-4.76%)
$12
1 years 1 months 11 days ago
(14-Nov-2023)
1/8 (12.5%)
$-0.1 (-9.09%)
8
Buy
$25
1 years 4 months 16 days ago
(09-Aug-2023)
0/2 (0%)
$18.31 (273.69%)
Sell
$3.5
$2.45 (233.33%)
$4
1 years 4 months 16 days ago
(09-Aug-2023)
3/4 (75%)
$0.48 (15.89%)
22
What is CARA (Cara Therapeutic) average time for price targets to be met?
Which analyst has the current highest performing score on CARA (Cara Therapeutic) with a proven track record?
Which analyst has the most public recommendations on CARA (Cara Therapeutic)?
Which analyst is the currently most bullish on CARA (Cara Therapeutic)?
Which analyst is the currently most reserved on CARA (Cara Therapeutic)?